Neladalkib

neladalkib · Nuvalent Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Neladalkib, covering 2025-10-30 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC or Other ALK+ Solid Tumors